Company number: 02949804
Charity number: 1073453
Centre for Research and Implementation of Clinieal Practice
(A company limited by guarantee)
Directors, report and financial statements
for the year ended 30 March 2024
•ADUE49&D*
1610112025
COMPANIES HOUSE
A6

Centre for Research and Implementation of Clinical Practice
(A compgny limited by guarantee)
Contents
Page
Legal and administrative infomaiion
Trustees, (directors) report
Independent ¢xamin¢rfs report
Staternent of financihl activities
Balance sheet
Notes to the financial slaternents
9-11

Centre for Research and Implementation of Clinical Practiee
(A company limited by guarantee)
Legal and administrative information
Charity number
1073453
Company registration number 02949804
Registered offi¢e
7-8 Ritz Parade
Western Avenue
London
W5 3RA
Charity Trustees (directors)
P J Franks
C J Moffatt
S G Murray
J A Stirlin8
Secretary
P J Franks
Independent examiner
Arvind Joshi FCA CTA DChA
Levy + Partners Limited
Chartered Accountants
7-8 Rilz Parade
Western Avenue
London
W5 3RA
Bankers
Barclays Barth plc
Fulham Broadway Branch
Hammersmith Business Centre Group
POBox738
London W6 9HY
Page I

Centre for Research and Implementation of Clinical Practice
(A company limited by guarantee)
Trustees, Report (incorporating the directors, report)
for the year ended 30 March 2024
The trustees, who are also directors of the charity for the purpose of the Companies Act 2006, present their report with
the financial statements of the chariiable company for the year ended 30 March 2024.
Principal activity and review
The Centre for Research and Implementation of Clinical Practice (CIUCP) is a private company limited by guarantee
and accordingly does not have a share capital. It was incorporated on 18 July 1994. The company was registered as a
charity on 22 January 1999. Th¢ Charity is known informally as the Centre for Research (CRJCP).
Slructure, governance And management
The company's governing documenl is the Memorandum and Articles of A550ciation, as amended by a special resolution
dated 22 November 2023.
Objectives and activities
The company's objectives and activilies are the evaluation and implementation of research based practice into the
treatment of chronic wounds, including leg ulceration, pressure ulceration and lymphoedema, through research,
education and audit.
A¢hlevements and performance
The company continues its work in lymphoedema and chronic wounds. The close partnership with the International
Lymphoedema Framework (ILF) continue5 Wlth the work expanding to take in new countries. Our publication policy
may change in that there is a possibility thal we will no longer be producing a third dedicated edition of Lynphali¢
Resear¢h & Biology, but this has yet lo be fJnalis¢d.
The Limprint database continues to offer us opportunities for new research, and Child Limprint is progressing well.
Financial review
In the period under review the company returned a deficit on ordinary activities..
Deficit on ordinary activities
Retained reserves brought forward
(33,896)
34,449
Retained reserve5 ca￿Led forward
553
Page 2

Centre for Research and Implementation of Clinical Practice
(A company limited by guarantee)
Trustees, Report (incorporating the directors, report)
for the year ended 30 March 2024
Future developments
The company's general income stream has become Challenging as Ihe regular income from our industy partners is no
longer available. The company continues to offer support to health care providers and companies by developing research
opportunities in the areas of wound care and lymphoedema. We continue to support AOTI in their work on venous leg
ulceration and a new project on diabetic foot ulceration.
Public benefit
The trustees confirni that they have referred to the guidance contained in the Charity Commission's general guidance on
public benefit when reviewing the charity's objectives and activities and in planning future activities.
The work undertaken by CRICP relates to Ihe management of important health issues. To advance these areas, CRICP
undertakes research wiih clinical partners lo develop patient orienlaled approaches lo describe th05e patients who suffer
from these conditions. and to examine the polential benefils of the appropriate management according to their own
health and quality of life, and the potential benefits to the health organisalions who manage them.
11 is the judgement of the trustees that activities in pursuit of the above objectives fijlly meei Ihe public benefit test,
which they have kept in mind in planning programrnes for the charity.
Statement of trustees, responslbllities
The trustees, who are also the directors of Centre for Research and Implementation of Clinical Practice for the purpose
of company law, are responsible for preparing Ihe Trustees, Report and Ihe accounts in accordance with applicable law
and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).
Company law requires the trustees lo prepare fmancial statements for each f￿ancial year. Under company law the
trustees must not approv¢ the finan¢i81 stat¢m¢nts unless they are satisfied that they give 8 true and fair view of th¢ stale
of affairs of the charitable company and of the incoming resources and application of resources, including the income
and expendiiure of the charitable company for that period. In preparing these financial staiements, the Irusiees are
required to..
select suitable a¢counting poli¢i¢s and ihen apply them consisiently*
observe the methods and principles in the Charities SORP.
make judgments and estimates Ihat are reasonable and prudent:
slate whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed
and explained in the accounts. and
prepare Ihe financial stal¢men15 on th¢ going concern basis unless it is inappropriate to presume that the charitable
company will continue in business.
The trustees are responsible for maintaining proper accounting records which disclos¢ with reasonable accuracy at any
time the f￿anCIal position of the charilable company and to enable them to ensure that the accounts comply with the
Companies Arl 2006. They are also r¢5ponsible for safeguarding the assets of the charitable company and hence for
taking reasonable steps for the prevention and detection of fraud and other irregularities.
The charity trustees who served during the year and up to the date of this report are set out on page l.
Page 3

Centre for Research and Implementatlon of Cllnlcal PrHctlce
(A company limlted by gllaraDtee)
Trllstees, Report (tncDrporatin£ tho direetors, report)
ror the year ended 30 March 2024
Auditors
Under ¢lwtsvk rw)lulion dAtcd 16 T)ec¢mber 1994 it was r¢solvd to dibTr¢ThS¢ with th¢ obli¥81ion ¢0 appoinl auditors
Dnually.
Undcr thc provisions of the Companie5 AGt¥ u¥ th¢ company is a sm&ll cornpany audit is DO lon¥
requir￿. Mc8srs. T£vy & PArtners bave sigthfied their WAllitistiess (o aclgs iodependent examiners.
This report
pproved by the Board on 8 January 2025 #nd tsignp3J on ils beh￿[bY..
P J Franks
Trustet (Director)
Pgge 4

Centre for Research and Implementation of Clinical Practice
(A company limited by guarantee)
Independent examiner's report to the trustees of Centre for Research and Implementation of
Clinical Practice.
I report to the charity trustees on my examination of the account5 of Centre for Research and Implementation of Clinical
Practice (a company limited by guarantee) for the year ended 30 March 2024, as sel out on pages 2 to I
Responsibilities and basis of report
As the charity's trustees (who are also the directors of the company for the purposes of company law), you are responsible
for the preparation of the accounls in accordance with the requirements of the Companies Aci 2006 ("the 2006 Act").
Having satisfied myself ihal the accounts of the Company are not required to be audited for this year under Part 16 of the
2006 Act and are eligible for independent examination, I report in respect of my examination of your charity's accounts as
Ca￿led out under section 145 of the Charities Act 2011 ("the 201 l Act"). In carrying out my examination, I have followed
the Directions given by the Charity Commission under section 145(5){b) of the 201 l Act.
Independent examlner's statement
I have completed my examinaiion. I confim that no material matters have com¢ to my attention which gives me Gause to
believe that..
l accounting records were not kept in accordan¢¢ with section 3 86 of the Companies Act 2006; or
2 the accounts do not accord with such records. or
3 Ihe accounts do not comply with relevant ac¢ounting requirements under section 396 of the Companies Act 2006 other
than any requirement that the accounts give a 'lrue and faiv view which is not a matter considered os part of an
independent examination: or
4 the accounts have noi been prepared in accordance wilh the Charities SORTr (FRS102),
I have no concerns and have come across no other matters in connection with the examination to which attention should be
drawn in this report in order to enable a proper understanding of the accounts to be reached.
Arvin
i FCA CTA DChA
Independent examiner
Le*y + Partners Limited
Chartered Accountants
7-8 Ritz Parade
Western Avenue
London W5 3RA
Date.. 8 January 2025
Page 5

Centre for Research and Implementation of Clinical Practice
(A company limited by guarantee)
Statement of financial activities (incorporating the income and expenditure account)
For the year ended 30 Mareh 2024
Unrestrlcted
fund$
2024
Total
2023
Total
Notes
Income
Research
Bank interest r¢c¢ived
35,694
360
35,694
360
65,500
187
Total income
36,054
36,054
65,687
Expenditure
Research cosls
Governance costs
33,580
36,370
33,580
36,370
44,714
45,513
Total expenditure
69,950
69,950
90,227
Net movement In funds
(33,896) (33,896)
(24,540)
Total funds brought forward
34.449
34,449
58,989
Total funds carried forward
553
553
34,449
All of the above amounts relate to continuing activities. There are no restricted funds.
There are no recognised gains or losses oiher than the surplus or deficit for the above two financial years.
The notes on pages 9 to 11 form an integral parl of these financlal statements.
Pag¢ 6

Centre for Research and Implementation of Clinical Praetiee
(A company limited by guarantee)
Balance sheet
as at 30 March 2024
2024
2023
Notes
Current assets
Cash at bank and in hand
9,098
44,768
9,098
44,768
Creditors: amounts falling
due within one year
(8,545)
(10,319)
Net current assets
553
34,449
Net assets
553
34,449
Funds of the charity
Unreslricied funds
553
34,449
Total charity funds
553
34,449
The Balance Sheet Continues on Ihe following page.
The notes on pages 9 ¢0 11 form an integral part of these financial statements.
Page 7

Centre for Research and TmplementatJoD of ClinlcAI Pracdce
(A company Ilmited by guarantee)
BalaDce sheet (eotttAti￿ed)
Trustees, (dlreetors) statements requiTed by the Companles Act 2006
for the year ended 30 March 2024
In rapproving these finunciul yÉdternL￿1ts a8 IruRteeR (di￿¢tors) of th¢ ¢haritubl¢ compaDy. ￿ h¢r¢by ￿nfiM}.
tltht for th¢ y¢af 8t&tcd abovc th¢ chBritsble compally was ell¢itlal lo thc txemption from an &udit under section 477 of
the Companies Act 2006,
The members have not Tequir¢d the ¢h&ritable compaoy to obiain an audit of its a¢wunts for the year in questioi) in
accel￿d￿Ce witb section 476 of the Act.
The tru8teeFJdir¢ctOTS a&nOwled￿ thir rcspvn¥ibilitie$ tor COLnplyin8 with thc rquironcnt¥ vf thc C,ompani&4 Acl
2006 with respect lo a￿oU￿till8 rncords and prcpAratiDn of aceounL8.
The finonci
statements wLrb' 4Wpr0v￿ by the board on 8 January 2025 and 8igtt¢d on its behalf by
P J Franks
Trustse (Dlreetor)
Company nuntber.. U2949804
Th¢ notes on p8g¢$ 9 to 11 form integral part frf these fiuancial statements.
Page 8

Centre for Research and Implementation of Clinical Practiee
(A Company limited by guarantee)
Notes to financial statements
for the year ended 30 Mareh 2024
Statement of compliance
The principal accounting policies are summarised below. The accounting policies have been applied consistently
throughout th¢ year and (h¢ preceding y¢ar.
Basis of accounting
The financial statements have been prepared under the historical cost convention and in accordance with the
Charities SORP (FRS 102) 'Accounting and Reporting by Charities- Statement of Recommended Practice
applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in
the UK and Republic of Ireland (FRS 102) (effective l January 2015), and the Companies Act 2006 as it applies
from l January 2015. The charity is a Public Benefit Entity as defined by FRS 102.
1.2. Income
All incoming resources are included in the statement of fLnancial acrivilies when the charity is entitled lo the
income and the amount can be quanlified with reasonable accuracy.
Income from investments is included in the year in which it is receivable.
1.3. Expenditure
Exp¢nditrJre is recognised in the period in which the expenditure is incurred. Expenditure includes any VAT
which cannot be fully recovered, and is reported as part of the expenditure to which it relates.
Charitable expenditure comprises those costs incurred by the charitable company in the delivery of its activities
and services for its beneficiaries. 11 includes both costs that can be allocated directly io such activities and those
costs of an indire¢i narure ne¢essory to support ihem.
Support cost5 are those costs incurred directly in support of expenditure on the objects of the charity and include
project management.
Research and development
Research expenditure is written off to the surplus/(d¢fi¢it) account in the year in which it is incurred,
Costs of charitable activities
Unrestricted
fund$
2024
Total
2023
Total
Wages & Salaries
33,580
33,580
44,714
33,580
33,580
44.714
Page 9

Centre for Research and Implementation of Clinical Practice
(A company limited by guarantee)
Notes to financial statements
for the year ended 30 Mareh 2024
Governance costs
Unrestrlcled
funds
2024
Total
2023
Tolal
Accountancy fees
Insuranc¢
Professional
Office costs
General expenses
Bank tharge5
Research & development costs
1,224
3,000
1.224
3,000
1,224
2,733
100
1,640
35
102
39,679
352
173
102
31,519
352
173
102
31,519
36,370
36,370
45,513
Employees
Employment costs
2024
2023
Wages and salaries
33,580
44,714
No employee received emoluments of more than £60,000 (2023 None).
Number of employees
The average monThly numbers of employees (including the trustees) during the year, calculated on the basis of
full time equivalents, was as follows:
2024
Iyumber
2023
Number
Taxation
The company is exempt from tax on its charitable activities as il is a registered charity.
Page 10

Centre for Research and Implementation of Clinical Praetice
(A company limited by guarantee)
Notes to financial statements
for the year ended 30 March 2024
Credltors: amounts falling due
within one year
2024
2023
Other creditors
Other taxes and social security
Other creditors
7,156
21
.368
7.156
,795
1,368
8,545
10,319
Unrestricted funds
At
At
31 March
2024
l April Incoming Outgoing
2023 resources
resources
Unrestricied Funds
34,449
36,054
(69,950)
553
Related party transactions
Stuart Moffatt, the husband of Christine Moffatt (a director), provides financial services to the company. The
charge for his services amounted io £lOO.
Going concern
The financial statemenls have been prepared on the assumption that the charitable company is able to carry on
operations as a going concern, which th¢ directors consider appropriate having regard to the circumstances.
10.
Company limited by guarantee
Centre for Research and Implemenlalion of Clinical Practice is a company limited by guarantee and accordingly
does not have a share capital.
The directors as members of the company. undertake to contribute such amount as may b¢ required not exceeding
£1 to the assets of the charitable company in th¢ ¢v¢nl of it5 being wound up while he or she is a member, or
within one year after he or sh¢ ceases lo be a member.
Pagell